Malawi vs Singapore: Estimated antiretroviral therapy coverage among people living with HIV
Malawi
89.0%
in 2025
Singapore
89.0%
in 2024
Malawi rank
22nd
Singapore rank
22nd
Estimated antiretroviral therapy coverage among people living with HIV over time
- Malawi
- Singapore
How they compare
Malawi currently reports 89.0% against 89.0% in Singapore, a difference of 0.0%.
Across all 25 years both countries report, Singapore has been ahead every year.
Malawi ranks 22nd and Singapore ranks 22nd of 143 countries.
Singapore has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malawi | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.1% | 20.5% | 14.4% | Singapore |
| 2010s | 56.9% | 74.8% | 17.9% | Singapore |
| 2020s | 86.8% | 87.8% | 1.0% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Malawi or Singapore?
- Malawi, at 89.0% against 89.0% in Singapore as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Malawi and Singapore?
- 0.0%, with Malawi ahead.
- How many years of comparable data are there for Malawi and Singapore?
- 25 years are reported by both, from 2000 to 2024.
- How do Malawi and Singapore rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Malawi ranks 22nd and Singapore ranks 22nd of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.